Stocky
OMER
Omeros Corporation
NASDAQ NMS - GLOBAL MARKET · Pharmaceuticals · US
12.80
▼ -1.08%

What's happening at Omeros Corporation

Omeros Corporation's latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 5 Aug 2026
Big update 20 Jul 2026

Completes $14.5 million convertible note repurchase

Company is reducing debt by buying back its own bonds, which can strengthen its financial position.

SEC 8-K · filed 2026-07-20 View filing ↗
Money 6 Jul 2026

Repurchases $16 million convertible notes, plans $14.5 million more

Reducing debt obligations shows management confidence and can improve the company's balance sheet over time.

SEC 8-K · filed 2026-07-06 View filing ↗
Governance 25 Jun 2026

Three directors elected; executive pay and auditor approved

Shareholders voted on leadership and oversight—key decisions about who runs the company and checks its finances.

SEC 8-K · filed 2026-06-25 View filing ↗
Money 18 Jun 2026

Agrees to repurchase up to $16 million convertible notes

Buying back debt means less money owed later, which can improve the company's financial health.

SEC 8-K · filed 2026-06-18 View filing ↗
Earnings 13 May 2026

First-quarter 2026 results announced

Quarterly earnings show how well the business is performing and whether revenue and costs are moving in the right direction.

SEC 10-Q · filed 2026-05-13 View filing ↗
Earnings 13 May 2026

First-quarter 2026 results announced

Quarterly earnings show how well the business is performing and whether revenue and costs are moving in the right direction.

SEC 8-K · filed 2026-05-13 View filing ↗
Earnings 31 Mar 2026

Full-year 2025 annual report filed

Annual report shows complete yearly financial results and lists all major assets, debts, and business operations.

SEC 10-K · filed 2026-03-31 View filing ↗

Common questions

How does Stocky track Omeros Corporation's company events?

Stocky reads Omeros Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Omeros Corporation's most recent SEC filing?

Omeros Corporation's most recent tracked filing was a 8-K on 20 Jul 2026: Completes $14.5 million convertible note repurchase.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Omeros Corporation's full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.